Ecofibre Limited (EOFBF)

Market Cap	4.68M
Revenue (ttm)	17.56M
Net Income (ttm)	-10.21M
Shares Out	n/a
EPS (ttm)	-0.03
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	14,642
Average Volume	n/a
Open	0.0700
Previous Close	0.0010
Day's Range	0.0700 - 0.0700
52-Week Range	0.0010 - 0.0800
Beta	1.08
RSI	0.06
Earnings Date	Aug 22, 2025

About Blueprint Medicines

Ecofibre Limited, together with its subsidiaries, engages in the polymer, health care, and hemp seed genetics businesses in the United States and Australia. The company operates through Ecofibre Advanced Technologies, Ananda Health, Ecofibre Genetics, and EOF Bio segments. It offers cannabinoid based health products for human and pet consumption. In addition, the company provides yarn, polymer textiles, and hemp related food products. Further, it is involved in patient-centered cannabinoid-based drug activities. Ecofibre Limited was incorporate...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2009
• Country: Australia
• Stock Exchange: OTCMKTS
• Ticker Symbol: EOFBF

Financial Performance

In 2024, Ecofibre's revenue was 27.98 million, a decrease of -8.67% compared to the previous year's 30.64 million. Losses were -44.34 million, 11.1% more than in 2023.